| Stage | TBI | % of rev | AEBI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $521M | 100.00% | $496M | 100.00% | TBI ×1.05 |
| Gross profit | $107M | 20.55% | $97M | 19.60% | TBI +0.9pp |
| Operating income | $12M | 2.30% | $27M | 5.45% | AEBI +3.1pp |
| Pre-tax income | $10M | 1.97% | $15M | 3.09% | AEBI +1.1pp |
| Net income | $9M | 1.78% | $10M | 2.11% | AEBI +0.3pp |
| Stage | TBI | AEBI | Gap · A − B |
|---|---|---|---|
| Revenue | $521M100.00% | $496M100.00% | TBI ×1.05 |
| Gross profit | 20.55%$107M | 19.60%$97M | TBI +0.9pp |
| Operating income | 2.30%$12M | 5.45%$27M | AEBI +3.1pp |
| Pre-tax income | 1.97%$10M | 3.09%$15M | AEBI +1.1pp |
| Net income |
| 1.78%$9M |
| 2.11%$10M |
| AEBI +0.3pp |
No shared counterparties.